Identification and characterization of a potential ischemia-selective N-methyl-D-aspartate (NMDA) receptor ion-channel blocker, CNS 5788.

Autor: Padmanabhan S; Cambridge NeuroScience, Inc., Norwood, MA 02602, USA. padman@cambneuro.com, Perlman ME, Zhang L, Moore D, Zhou D, Fischer JB, Durant GJ, McBurney RN
Jazyk: angličtina
Zdroj: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2001 Feb 26; Vol. 11 (4), pp. 501-4.
DOI: 10.1016/s0960-894x(00)00695-8
Abstrakt: The identification and characterization of a potentially ischemia-selective and orally-active sulfoxide based NMDA ion-channel blocker showing good neuroprotective activity, (R)-(+)-N-(2-chloro-5-methylthiophenyl)-N'-(3-methylsulfinylphenyl)-N'-methylguanidine (CNS 5788), is described.
Databáze: MEDLINE